Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04353570
Other study ID # 10477M-IMPA
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 1, 2020
Est. completion date July 30, 2020

Study information

Verified date April 2020
Source Centre hospitalier de Ville-Evrard, France
Contact Youcef BENCHERIF
Phone 0782723674
Email youcef.bencherif@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This clinical interview is made to allow a clinical follow-up of the patients followed in psychiatry of the EPS Ville-Evrard establishment in a simple way and in a secure medical framework during the period of the epidemic and the confinement from March 30 to June 30, 2020.


Recruitment information / eligibility

Status Recruiting
Enrollment 2100
Est. completion date July 30, 2020
Est. primary completion date June 18, 2020
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

Adult patient followed in outpatient psychiatry at EPS Ville Evrard and agrees to participate -

Exclusion Criteria:

Adult patient followed in outpatient psychiatry at EPS Ville Evrard and does not wish to participate

-

Study Design


Related Conditions & MeSH terms

  • Identify the Psychological Impact of Containment

Intervention

Other:
clinical interview
This interview can be carried out face to face or remotely. In the latter case, it is part of telemedicine, which is recognised by the health authorities in France.

Locations

Country Name City State
France Unité de recherche clinique Neuilly Sur Marne Île De France

Sponsors (1)

Lead Sponsor Collaborator
Centre hospitalier de Ville-Evrard, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Depression MINI DIAG and Anxiety questionnaire and the The Global Performance Rating Scale and CGI-truth three month